McNamara B, Greenman M, Bellone S, Santin LA, et al. Preclinical activity of datopotamab deruxtecan, a novel TROP2 directed antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (TROP2) in ovarian carcinoma. Gynecol Oncol 2024;189:16-23.
PMID: 38981151